AIJIEWEI®:Tofacitinib Citrate Tablets
AIJIEWEI®:Tofacitinib Citrate Tablets
  • Seen : 143 View

0
AIJIEWEI®:Tofacitinib Citrate Tablets

AIJIEWEI® has passed consistency evaluation and entered the fourth national VBP. It blocks the JAK signal pathway by intracellular targeting and regulates various inflammatory factors associated with Ra, achieves potent and rapid improvement of traditional DMARDs in rheumatoid arthritis patients with poor efficacy, and is recommended by Chinese and International Authority RA guidelines.

 

Saler Company Information

Company : Jiangsu Simcere Pharmaceutical Co., Ltd
Phone : 00862585566666
More Information : View
Online order registration form
No comments have been posted yet
loading
Your comment has been sent
AIJIEWEI®:Tofacitinib Citrate Tablets

AIJIEWEI® has passed consistency evaluation and entered the fourth national VBP. It blocks the JAK signal pathway by intracellular targeting and regulates various inflammatory factors associated with Ra, achieves potent and rapid improvement of traditional DMARDs in rheumatoid arthritis patients with poor efficacy, and is recommended by Chinese and International Authority RA guidelines.

 

Saler Company Information

Company : Jiangsu Simcere Pharmaceutical Co., Ltd
Phone : 00862585566666
More Information : View
Online order registration form